Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2025-12-24 @ 7:57 PM
NCT ID:
NCT04645004
Eligibility Criteria:
Inclusion Criteria:
* \<16 weeks' gestational age
* Singleton pregnancy
* Plan to take 81mg aspirin due to high risk history (below), but not yet initiated
* ≥1 risk factor:
* Chronic hypertension
* Type I or II diabetes
* Previous preeclampsia
* Renal disease
* Autoimmune disease (SLE) OR
≥2 risk factor:
* Nulliparity
* IVF pregnancy
* Black race or socioeconomic disadvantaged
* BMI\>30
* Prior adverse pregnancy outcome
Exclusion Criteria:
* Contraindication to aspirin
* Current or planned use of any other anticoagulation
* Current need for dialysis
* Use of aspirin therapy prior to enrollment in the current pregnancy
* Thrombocytopenia (\<150)
* Other known platelet disorder/thrombophilia at enrollment
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
13 Years
Maximum Age:
55 Years
Study:
NCT04645004
Study Brief:
Protocol Section:
NCT04645004